Literature DB >> 14136871

VINCRISTINE IN CHILDREN WITH MALIGNANT SOLID TUMORS.

D H JAMES, P GEORGE.   

Abstract

Entities:  

Keywords:  ADOLESCENCE; ANTINEOPLASTIC AGENTS; CARCINOMA, EPIDERMOID; CHILD; FIBROSARCOMA; HODGKIN'S DISEASE; INFANT; LYMPHOSARCOMA; NEPHROBLASTOMA; NERVOUS SYSTEM; NEUROBLASTOMA; RADIOGRAPHY; REFLEX, ABNORMAL; RETINOBLASTOMA; SARCOMA, EWING'S; SARCOMA, OSTEOGENIC; TERATOID TUMOR; TOXICOLOGIC REPORT; VINCRISTINE

Mesh：

Substances：

Year:  1964        PMID： 14136871     DOI： 10.1016/s0022-3476(64)80343-7

Source DB:  PubMed          Journal:  J Pediatr        ISSN： 0022-3476            Impact factor:   4.406


× No keyword cloud information.
  7 in total

Review 1.  Relevance of historical therapeutic approaches to the contemporary treatment of pediatric solid tumors.

Authors:  Daniel M Green; Larry E Kun; Katherine K Matthay; Anna T Meadows; William H Meyer; Paul A Meyers; Sheri L Spunt; Leslie L Robison; Melissa M Hudson
Journal:  Pediatr Blood Cancer       Date:  2013-02-15       Impact factor: 3.167

2.  Extravasation injury potential of CI-980, a novel synthetic mitotic inhibitor.

Authors:  J R MacDonald; D G Pegg
Journal:  Cancer Chemother Pharmacol       Date:  1993       Impact factor: 3.333

3.  Ewing sarcoma: an eponym window to history.

Authors:  Timothy P Cripe
Journal:  Sarcoma       Date:  2010-12-01

4.  Initial testing (stage 1) of eribulin, a novel tubulin binding agent, by the pediatric preclinical testing program.

Authors:  E Anders Kolb; Richard Gorlick; C Patrick Reynolds; Min H Kang; Hernan Carol; Richard Lock; Stephen T Keir; John M Maris; Catherine A Billups; Christopher Desjardins; Raushan T Kurmasheva; Peter J Houghton; Malcolm A Smith
Journal:  Pediatr Blood Cancer       Date:  2013-03-28       Impact factor: 3.167

5.  A phase II study of eribulin in recurrent or refractory osteosarcoma: A report from the Children's Oncology Group.

Authors:  Michael S Isakoff; Robert Goldsby; Doojduen Villaluna; Mark D Krailo; Pooja Hingorani; Anderson Collier; Carol D Morris; E Anders Kolb; John J Doski; Richard B Womer; Richard Gorlick; Katherine A Janeway
Journal:  Pediatr Blood Cancer       Date:  2018-10-30       Impact factor: 3.167

6.  Antidote studies of vinorelbine-induced skin ulceration in the mouse.

Authors:  R T Dorr; K L Bool
Journal:  Cancer Chemother Pharmacol       Date:  1995       Impact factor: 3.333

7.  Outcome and toxicity of an Ifosfamide-based soft tissue sarcoma treatment protocol in children. The importance of local therapy.

Authors:  S M Yule; R Skinner; M W English; M Cole; A D Pearson; H H Lucraft; A W Craft
Journal:  Sarcoma       Date:  1998
  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.